journal article·2021-09-26Open access

Age- and Sex-Adjusted Reference Intervals in Tear Cytokine Levels in Healthy Subjects

Itziar Fernández, Amalia Enríquez-de-Salamanca, Alejandro Portero, Carmen García-Vázquez, Margarita Calonge, José M. Herreras

Applied Sciences· Volume 11· Issue 19

Abstract

Alterations in tear cytokine levels have been associated with various ocular disorders as compared to those in healthy subjects. However, age and sex are not always considered in these comparisons. In this study we aimed to establish age and sex reference intervals (RIs) for tear cytokine levels in healthy people. Tear samples were taken from 75 males and 82 females, aged 18–88 years, and tear cytokine levels were determined. Age- and sex-adjusted RIs for epidermal growth factor (EGF), fractalkine, interleukin (IL)-1 receptor antagonist (RA), IL-7, IL-8, interferon inducible protein (IP)-10, monocyte chemotactic protein (MCP)-1, and vascular endothelial growth factor (VEGF) tear cytokine levels in a healthy sample were established using generalized additive for location, scale and shape (GAMLSS) models. RIs were tested in two external samples: a validation sample of 40 individuals with normal results at four Dry Eye Disease (DED) clinical diagnostic tests (OSDI, T-BUT, corneal staining and Schirmer test); and a utility sample of 13 severe DED cases. IL-1RA, IL-8, IP-10, and MCP-1 levels showed a positive association with age, while EGF was negatively correlated. IL-7 concentration increased up to 40 years and again after 70 years, observing a quasi-linear decrease between them. For VEGF, higher levels were observed in the middle-aged range. Regarding sex-influence, fractalkine tear levels were higher in men, whereas those of IL-7, IL-8, and IP-10 were higher in women. Using the estimated age- and sex-adjusted RIs, more than 92% of the validation sample was correctly classified, and 100% of the severe DED patients in the utility sample had concentrations outside the RIs in at least two of the cytokines evaluated.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ocular Surface and Contact Lens · Glaucoma and retinal disorders · Allergic Rhinitis and Sensitization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

IOBA (Institute of Applied Ophthalmobiology), University of Valladolid, E-47011 Valladolid, Spain

Department of Statistics and Operations Research, Universidad de Valladolid, E-47011 Valladolid, Spain

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), E-47011 Valladolid, Spain

Ophthalmology Service, University Clinic Hospital, E-47003 Valladolid, Spain

References (66)

Show source-provided references
1. Monastero, R.N., and Pentyala, S. (2017). Cytokines as biomarkers and their respective clinical cutoff levels. Int. J. Inflamm., 4309485.10.1155/2017/4309485 ↗
2. Tears as a source of biomarkers for ocular and systemic diseases10.1016/j.exer.2013.07.015 ↗
3. Tear fluid biomarkers in ocular and systemic disease: Potential use for predictive, preventive and personalised medicine10.1186/s13167-016-0065-3 ↗
4. Review of biomarkers in ocular matrices: Challenges and opportunities10.1007/s11095-019-2569-8 ↗
5. The growing need for validated biomarkers and endpoints for dry eye clinical research10.1167/iovs.17-21709 ↗
6. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction10.1016/j.jprot.2012.11.017 ↗
7. Diagnostic performance of a tear protein panel in early dry eye
8. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial
9. Dry eye as a mucosal autoimmune disease10.3109/08830185.2012.748052 ↗
10. TFOS DEWS II Definition and Classification Report10.1016/j.jtos.2017.05.008 ↗
11. Tear analysis in ocular surface diseases10.1016/j.preteyeres.2012.06.002 ↗
12. Age-related changes to human tear composition10.1167/iovs.17-23358 ↗
13. Cytokine and chemokine levels in tears from healthy subjects
14. Multiple cytokine analysis in human tears: An optimized procedure for cytometric bead-based assay10.1080/02713680802190085 ↗
15. Normal tear protein profiles and age-related changes10.1136/bjo.68.5.316 ↗
16. Age-associated changes in human tear proteome10.1186/s12014-019-9233-5 ↗
17. Generalized additive models for location, scale and shape (with discussion)
18. Construction of the World Health Organization child growth standards: Selection of methods for attained growth curves10.1002/sim.2227 ↗
19. Chamitava, L., Garcia-Larsen, V., Cazzoletti, L., Degan, P., Pasini, A., Bellisario, V., Corsico, A.G., Nicolis, M., Olivieri, M., and Pirina, P. (2018). Determination of adjusted reference intervals of urinary biomarkers of oxidative stress in healthy adults using GAMLSS models. PLoS ONE, 13.10.1371/journal.pone.0206176 ↗
20. Reference centiles for the middle cerebral artery and umbilical artery pulsatility index and cerebro-placental ratio from a low-risk population—A Generalised Additive Model for Location, Shape and Scale (GAMLSS) approach10.1080/14767058.2018.1432590 ↗
21. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease
22. Cytokine and chemokine tear levels in patients with uveitis
23. Estimation of descriptive statistics for multiply censored water quality data10.1029/WR024i012p01997 ↗
24. Information measures and model selection
25. Randomised quantile residuals10.1080/10618600.1996.10474708 ↗
26. Worm plot: A simple diagnostic device for modelling growth reference curves10.1002/sim.746 ↗
27. TFOS Dry Eye workshop (DEWS) II Diagnostic methodology report10.1016/j.jtos.2017.05.001 ↗
28. CLSI (2008). Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, Clinical and Laboratory Standards Institute. [3rd ed.]. CLSI Document EP28-A3c.
29. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research10.1097/MCO.0b013e32833cf3bc ↗
30. Genser, B., Cooper, P.J., Yazdanbakhsh, M., Barreto, M.L., and Rodrigues, L.C. (2007). A guide to modern statistical analysis of immunological data. BMC Immunol., 8.10.1186/1471-2172-8-27 ↗
31. Age and age-related diseases: Role of inflammation triggers and cytokines10.3389/fimmu.2018.00586 ↗
32. Inflamm-aging. An evolutionary perspective on immunosenescence10.1111/j.1749-6632.2000.tb06651.x ↗
33. An update on inflamm-aging: Mechanisms, prevention, and treatment10.1155/2016/8426874 ↗
34. Inflammatory mediators in the elderly10.1016/j.exger.2004.01.009 ↗
35. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing10.1016/j.cyto.2006.03.012 ↗
36. CSF cytokines in aging, multiple sclerosis, and dementia10.3389/fimmu.2019.00480 ↗
37. Effects of ageing on the immune system: Infants to elderly10.1111/sji.12413 ↗
38. Can an increased level of circulating IL-8 be a predictor of human longevity?
39. The role of IL-1 gene cluster in longevity: A study in Italian population10.1016/S0047-6374(03)00033-2 ↗
40. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: The vitality 90+ study10.1093/gerona/62.9.1016 ↗
41. Interleukin-7 and immunosenescence10.1155/2017/4807853 ↗
42. Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: Implications for the neolymphogenesis at the limit of human life10.1111/j.1474-9726.2006.00204.x ↗
43. Ruggiero, D., Dalmasso, C., Nutile, T., Sorice, R., Dionisi, L., Aversano, M., Bröet, P., Leutenegger, A.L., Bourgain, C., and Ciullo, M. (2011). Genetics of VEGF serum variation in human isolated populations of cilento: Importance of VEGF polymorphisms. PLoS ONE, 6.10.1371/journal.pone.0016982 ↗
44. Saldías, M.P., Fernández, C., Morgan, A., Díaz, C., Morales, D., Jaña, F., Gómez, A., Silva, A., Briceño, F., and Oyarzún, A. (2017). Aged blood factors decrease cellular responses associated with delayed gingival wound repair. PLoS ONE, 12.10.1371/journal.pone.0184189 ↗
45. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting10.1016/j.jacc.2003.07.025 ↗
46. Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia10.1186/s13195-018-0385-8 ↗
47. Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis10.3109/17453674.2011.645195 ↗
48. InflammAging at ocular surface: Clinical and biomolecular analyses in healthy volunteers10.1167/iovs.18-25822 ↗
49. Inflammaging: Should this term be suitable for age related macular degeneration too?10.1007/s00011-013-0684-2 ↗
50. The role of inflammation in the pathogenesis of glaucoma10.1016/j.survophthal.2012.08.010 ↗
51. Glaucoma history and risk factors10.1016/j.optom.2016.02.003 ↗
52. Effects of natural aging and gender on pro-inflammatory markers10.1590/1414-431x20198392 ↗
53. Cytokines and chemokines in immune-based ocular surface inflammation10.1586/1744666X.4.4.457 ↗
54. Molecular and cellular biomarkers in dry eye disease and ocular allergy10.1097/ACI.0b013e328357b488 ↗
55. Tear cytokine profiles in dysfunctional tear syndrome10.1016/j.ajo.2008.08.032 ↗
56. Analysis of inflammatory cytokines in the tears of dry eye patients10.1097/ICO.0b013e3181a16578 ↗
57. Expression of CCR5 and its ligands CCL3, −4, and −5 in the tear film and ocular surface of patients with dry eye disease10.3109/02713683.2011.622852 ↗
58. Evaluations of tear protein markers in dry eye disease: Repeatability of measurement and correlation with disease10.1167/iovs.11-9054 ↗
59. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease10.1167/iovs.11-9417 ↗
60. Monroy, D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca10.1076/ceyr.19.3.201.5309 ↗
61. Abnormal protein profiles in tears with dry eye syndrome10.1016/S0002-9394(03)00203-4 ↗
62. Prehematopoietic stem cell transplantation tear cytokines as potential susceptibility biomarkers for ocular chronic Graft-Versus-Host disease10.1167/iovs.17-21670 ↗
63. Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation10.1136/bjophthalmol-2017-310373 ↗
64. Dry eye in Sjögren’s Syndrome: Chemokine and Cytokine tear spectrum
65. Correlations between tear IP-10 and other biomarkers in normal and dry eye patients
66. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome10.1167/iovs.09-3425 ↗